ALB and blood coagulation disease: Approximately 80% of rifampicin in the blood is bound to proteins (predominantly albumins) and is excreted equally by bile and urine.[23] It is reasonable to assume that a drug with such pharmacokinetics may increase the likelihood of a drug side effect if its clearance is reduced, and in this case, coagulopathy occurs.